1. Home
  2. MCRB vs TAYD Comparison

MCRB vs TAYD Comparison

Compare MCRB & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$17.19

Market Cap

162.7M

Sector

Health Care

ML Signal

HOLD

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

N/A

Current Price

$48.21

Market Cap

132.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MCRB
TAYD
Founded
2010
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
162.7M
132.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
MCRB
TAYD
Price
$17.19
$48.21
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$14.33
N/A
AVG Volume (30 Days)
323.3K
4.6K
Earning Date
11-05-2025
01-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.62
2.72
Revenue
$351,000.00
$44,593,219.00
Revenue This Year
N/A
$10.81
Revenue Next Year
N/A
$8.37
P/E Ratio
$28.23
$18.07
Revenue Growth
N/A
N/A
52 Week Low
$6.53
$29.50
52 Week High
$29.98
$53.73

Technical Indicators

Market Signals
Indicator
MCRB
TAYD
Relative Strength Index (RSI) 49.93 53.85
Support Level $16.61 $47.74
Resistance Level $18.86 $50.56
Average True Range (ATR) 3.42 1.31
MACD -0.19 0.03
Stochastic Oscillator 11.70 68.16

Price Performance

Historical Comparison
MCRB
TAYD

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: